ロード中...
Isavuconazole treatment for rare fungal diseases and for invasive aspergillosis in patients with renal impairment: Challenges and lessons of the VITAL trial
Invasive fungal disease (IFD) confers a substantial risk for morbidity and mortality to immunocompromised patients. Invasive aspergillosis (IA) is the most common IFD caused by moulds but the prevalence of other rare mould diseases, such as mucormycosis, hyalohyphomycosis and phaeohyphomycosis, may...
保存先:
| 出版年: | Mycoses |
|---|---|
| 主要な著者: | , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2018
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6490690/ https://ncbi.nlm.nih.gov/pubmed/29570857 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/myc.12769 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|